These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17690595)

  • 1. Open-label escitalopram treatment for pathological skin picking.
    Keuthen NJ; Jameson M; Loh R; Deckersbach T; Wilhelm S; Dougherty DD
    Int Clin Psychopharmacol; 2007 Sep; 22(5):268-74. PubMed ID: 17690595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial of fluoxetine in pathologic skin picking.
    Simeon D; Stein DJ; Gross S; Islam N; Schmeidler J; Hollander E
    J Clin Psychiatry; 1997 Aug; 58(8):341-7. PubMed ID: 9515971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial.
    Grant JE; Chamberlain SR; Redden SA; Leppink EW; Odlaug BL; Kim SW
    JAMA Psychiatry; 2016 May; 73(5):490-6. PubMed ID: 27007062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder.
    Dougherty DD; Jameson M; Deckersbach T; Loh R; Thompson-Hollands J; Jenike M; Keuthen NJ
    Int Clin Psychopharmacol; 2009 Nov; 24(6):306-11. PubMed ID: 19730388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine.
    O'Sullivan RL; Phillips KA; Keuthen NJ; Wilhelm S
    Psychosomatics; 1999; 40(1):79-81. PubMed ID: 9989126
    [No Abstract]   [Full Text] [Related]  

  • 7. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.
    Dell'Osso B; Hadley S; Allen A; Baker B; Chaplin WF; Hollander E
    J Clin Psychiatry; 2008 Mar; 69(3):452-6. PubMed ID: 18312057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-injurious skin picking: clinical characteristics and comorbidity.
    Wilhelm S; Keuthen NJ; Deckersbach T; Engelhard IM; Forker AE; Baer L; O'Sullivan RL; Jenike MA
    J Clin Psychiatry; 1999 Jul; 60(7):454-9. PubMed ID: 10453800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.
    Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B
    Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
    Denys D; van Megen HJ; Westenberg HG
    J Psychopharmacol; 2003 Mar; 17(1):127-9. PubMed ID: 12680750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in pathologic skin-picking: open-label and double-blind results.
    Bloch MR; Elliott M; Thompson H; Koran LM
    Psychosomatics; 2001; 42(4):314-9. PubMed ID: 11496020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram in the treatment of obsessive-compulsive disorder.
    Zohar J
    Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichotillomania and skin-picking: a phenomenological comparison.
    Lochner C; Simeon D; Niehaus DJ; Stein DJ
    Depress Anxiety; 2002; 15(2):83-6. PubMed ID: 11891999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
    Grant JE; Potenza MN
    Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram prevents relapse of obsessive-compulsive disorder.
    Fineberg NA; Tonnoir B; Lemming O; Stein DJ
    Eur Neuropsychopharmacol; 2007; 17(6-7):430-9. PubMed ID: 17240120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label study of duloxetine for the treatment of obsessive-compulsive disorder.
    Dougherty DD; Corse AK; Chou T; Duffy A; Arulpragasam AR; Deckersbach T; Jenike MA; Keuthen NJ
    Int J Neuropsychopharmacol; 2015; 18(2):. PubMed ID: 25637377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.